{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:41:56Z","timestamp":1791333716627,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.vaccine.2006.10.031","type":"journal-article","created":{"date-parts":[[2006,10,31]],"date-time":"2006-10-31T20:31:26Z","timestamp":1162326686000},"page":"2832-2838","source":"Crossref","is-referenced-by-count":154,"title":["Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model"],"prefix":"10.1016","volume":"25","author":[{"given":"Lanying","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Jian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5664","key":"10.1016\/j.vaccine.2006.10.031_bib1","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1126\/science.1092002","article-title":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China","volume":"303","author":"Chinese SARS Molecular Epidemiology Consortium","year":"2004","journal-title":"Science"},{"issue":"5643","key":"10.1016\/j.vaccine.2006.10.031_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.1087139","article-title":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China","volume":"302","author":"Guan","year":"2003","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2006.10.031_bib3","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1073\/pnas.0409608102","article-title":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human","volume":"102","author":"Song","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"39","key":"10.1016\/j.vaccine.2006.10.031_bib4","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1073\/pnas.0506735102","article-title":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats","volume":"102","author":"Lau","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5748","key":"10.1016\/j.vaccine.2006.10.031_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2006.10.031_bib6","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3201\/eid1010.040445","article-title":"Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China","volume":"10","author":"Liang","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"5671","key":"10.1016\/j.vaccine.2006.10.031_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.304.5671.659","article-title":"Infectious diseases. Mounting lab accidents raise SARS fears","volume":"304","author":"Normile","year":"2004","journal-title":"Science"},{"issue":"5624","key":"10.1016\/j.vaccine.2006.10.031_bib8","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1085953","article-title":"The Genome sequence of the SARS-associated coronavirus","volume":"300","author":"Marra","year":"2003","journal-title":"Science"},{"issue":"5624","key":"10.1016\/j.vaccine.2006.10.031_bib9","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"issue":"6965","key":"10.1016\/j.vaccine.2006.10.031_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2006.10.031_bib11","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","article-title":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2","volume":"24","author":"Li","year":"2005","journal-title":"EMBO J"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2006.10.031_bib12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV neutralizing antibodies","volume":"86","author":"Faber","year":"2005","journal-title":"J Gen Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.10.031_bib13","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1128\/JVI.00083-06","article-title":"Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design","volume":"80","author":"He","year":"2006","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2006.10.031_bib14","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1016\/j.vaccine.2006.01.059","article-title":"A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice","volume":"24","author":"Zhou","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.031_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2005.06.016","article-title":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine","volume":"340","author":"Kapadia","year":"2005","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2006.10.031_bib16","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/JVI.79.5.2678-2688.2005","article-title":"Recombinant modified vaccinia virus ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region","volume":"79","author":"Chen","year":"2005","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2006.10.031_bib17","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2006.10.031_bib18","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1099\/vir.0.80111-0","article-title":"Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine","volume":"85","author":"Pang","year":"2004","journal-title":"J Gen Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.10.031_bib19","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.vaccine.2005.06.038","article-title":"Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine","volume":"24","author":"Qin","year":"2006","journal-title":"Vaccine"},{"issue":"6982","key":"10.1016\/j.vaccine.2006.10.031_bib20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.vaccine.2006.10.031_bib21","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1128\/JVI.79.22.13915-13923.2005","article-title":"Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization","volume":"79","author":"Kong","year":"2005","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.10.031_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.vaccine.2005.08.055","article-title":"A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses","volume":"24","author":"Spruth","year":"2006","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2006.10.031_bib23","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J Virol"},{"issue":"9427","key":"10.1016\/j.vaccine.2006.10.031_bib24","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(04)16501-X","article-title":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS","volume":"363","author":"Bukreyev","year":"2004","journal-title":"Lancet"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2006.10.031_bib25","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.vaccine.2005.01.033","article-title":"Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets","volume":"23","author":"Czub","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.10.031_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.virol.2006.03.049","article-title":"Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: implication for developing SARS vaccines","volume":"353","author":"Du","year":"2006","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2006.10.031_bib27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1089\/hum.2006.17.500","article-title":"Efficacy of severe acute respiratory syndrome vaccine based on a nonhuman primate adenovirus in the presence of immunity against human adenovirus","volume":"17","author":"Zhi","year":"2006","journal-title":"Hum Gene Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.031_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.virol.2005.01.042","article-title":"Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein","volume":"334","author":"Bisht","year":"2005","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2006.10.031_bib29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1073\/pnas.0409065102","article-title":"Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses","volume":"102","author":"Yang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.031_bib30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2004.09.106","article-title":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine","volume":"324","author":"He","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.vaccine.2006.10.031_bib31","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","article-title":"Receptor-binding domain of SARS coronavirus spike protein contains multiple conformational-dependant epitopes that induce highly potent neutralizing antibodies","volume":"174","author":"He","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.031_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/vim.2005.18.327","article-title":"Vaccine design for severe acute respiratory syndrome coronavirus","volume":"18","author":"He","year":"2005","journal-title":"Viral Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.10.031_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2005.01.034","article-title":"Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines","volume":"334","author":"He","year":"2005","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.vaccine.2006.10.031_bib34","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.4049\/jimmunol.176.10.6085","article-title":"Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein","volume":"176","author":"He","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.10.031_bib35","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.4049\/jimmunol.173.6.4050","article-title":"Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines","volume":"173","author":"He","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.031_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbrc.2004.10.052","article-title":"Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry","volume":"325","author":"He","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.vaccine.2006.10.031_bib37","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.vaccine.2004.07.031","article-title":"Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice","volume":"23","author":"Qu","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.031_bib38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3201\/eid1002.030799","article-title":"Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003","volume":"10","author":"Zhai","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2006.10.031_bib39","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1128\/JVI.78.17.9007-9015.2004","article-title":"Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein","volume":"78","author":"Giroglou","year":"2004","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.10.031_bib40","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0306446101","article-title":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry","volume":"101","author":"Simmons","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.vaccine.2006.10.031_bib41","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3201\/1107.050219","article-title":"SARS vaccine development","volume":"11","author":"Jiang","year":"2005","journal-title":"Emerg Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06011534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06011534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T15:55:05Z","timestamp":1547222105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06011534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":41,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0264410X06011534"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.10.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}